AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Top 29%
#1621 out of 5550 analysts
Average Return
+2.35%
Win Rate
63%25 out of 40
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viridian Therapeutics IncVRDN | +76.72% | $13.96 | $24.67 | 2026-04-07 - 2026-10-30 | Buy |
Eyepoint IncEYPT | +46.20% | $8.81 | $12.88 | 2025-06-17 - 2026-06-16 | Buy |
Viridian Therapeutics IncVRDN | +40.73% | $17.53 | $24.67 | 2026-05-06 - 2026-10-30 | Buy |
Viridian Therapeutics IncVRDN | +36.18% | $16.53 | $22.51 | 2025-08-07 - 2026-08-06 | Buy |
Viridian Therapeutics IncVRDN | +34.30% | $18.37 | $24.67 | 2026-06-30 - 2026-10-30 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
United Therapeutics CorpUTHR | 8 | Buy | $697.00 | +16.42% | Maintains | 9 days ago |
Eyepoint IncEYPT | 5 | Hold | $1.00 | +187.36% | Maintains | 12 days ago |
Rhythm Pharmaceuticals IncRYTM | 6 | Buy | $159.00 | +71.76% | Maintains | 23 days ago |
Mirum Pharmaceuticals IncMIRM | 4 | Buy | $155.00 | +82.35% | Maintains | 23 days ago |
Viridian Therapeutics IncVRDN | 8 | Buy | $38.00 | +54.03% | Maintains | a month ago |
Meiragtx Holdings PLCMGTX | 5 | Buy | $27.00 | +184.51% | Maintains | 3 months ago |
Krystal Biotech IncKRYS | 1 | Buy | $400.00 | +20.38% | Initiates Coverage On | 3 months ago |
Opus Genetics IncIRD | 1 | Buy | $9.00 | +145.23% | Maintains | 3 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $30.00 | +330.42% | Reiterates | 6 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Buy | $35.00 | +194.12% | Maintains | 7 months ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $21.00 | -48.82% | Maintains | 8 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.